Answer
These treatments may increase bleeding risk. The cancer team must assess concurrent use, and warfarin or other vitamin K antagonists should not be given with acalabrutinib.
Sources for this answer
- Calquence 100 mg film-coated tabletsemc · SmPC Current selected SmPC · Version 8